Press Releases
Physician’s Preference Warns of FDA’s Assault on Dietary Supplements in US Physician’s Preference
Physician’s Preference, vitamins & supplements, (PPVS) warns Americans of an immediate threat to all dietary supplements formulated in the United States after 1994. The U.S. Food and Drug Administration’s (FDA) most recent assault on the nutritional industry emerges from...
Press Releases
ELC GROUP aim to foster strategic and economic ties within India and China
ELC GROUP, the pan-European pharmaceutical regulatory affairs organisation, announced today that its experts would be visiting China and India next month to boost partnerships and discuss future collaborations with leading regional pharmaceutical companies. The visit...
Press Releases
DaVita Rx Delivers Five Millionth Prescription
DaVita Rx, the world’s first and largest full-service pharmacy dedicated to serving the unique needs of kidney patients, announced today that it has filled five million prescriptions since the company started delivering medications in 2005. ...
Press Releases
Metabolons Vitamin D Deficiency Test Now Available for Patient Analysis Metabolon
Metabolon, Inc., the leader in metabolomics, biomarker discovery and biochemical analysis, announced today that it is now offering a tandem mass spectrometry (LC/MS/MS) test for detection of Vitamin D deficiency. The test is being run in Metabolon’s high-complexity CLIA...
Press Releases
National Labor Union Apologizes for False and Defamatory Mass Mailing SUTTER HEALTH
A large, national labor union will pay Sutter Health $6 million and has formally apologized for sending false and disparaging postcards to consumers in numerous communities served by Sutter-affiliated hospitals and birthing centers. The apology...
Press Releases
Diamyd Appoints Peter Zerhouni as President Diamyd Medical
Peter Zerhouni has been involved in all aspects of the Company since 2006 and he is since April 2011 Acting President and CEO of the Company. He assumes his position as President and CEO of Diamyd Medical AB on...
Press Releases
Merck Receives Approval to Market GARDASIL®, ZOLINZA® and CUBICIN® in Japan
Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the Japanese Ministry of Health, Labour and Welfare (MHLW) approved three products - GARDASIL® , ZOLINZA® (vorinostat) and CUBICIN® (daptomycin for injection) – for...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read